Medtentia International Ltd Oy
USPTO PatentsView assignee record - 38 granted patents across 4 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, Medtentia ranks #8,435 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 4 technology areas.
- #8,435
- of 49,997 US assignees by volume
- 39th percentile
- by Innovation Score (31.8/100)
- 14.0
- avg claims per patent
- +24%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R8435 · Foreign Corporation #8,435 · 38 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-SMALL 38 grants
- UPPER-Q #8,435/49,997
- PHOTO-FINISH Malwarebytes
- CPC-NARROW A61F · 4 areas
- INNOV-THIN 31.8/100
- CLAIMS-RICH 14.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +24% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Malwarebytes Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Medtentia’s 31.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Medtentia
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- C B Worldwide · near 32
C B Worldwide · near
32 score
- GW Pharma · near 32
GW Pharma · near
32 score
- Medtentia Internatio… · this assignee 32
Medtentia Internatio… · this assignee
32 score
- Semnur Pharmaceuticals · near 32
Semnur Pharmaceuticals · near
32 score
- Silgan Plastics · near 32
Silgan Plastics · near
32 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Medtentia's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Medtentia?
Each dot is one of Medtentia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtentia’s own 14.0 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Medtentia's grants concentrate
Medtentia International Ltd Oy is a focused PatentsView assignee: 4 CPC subclasses with 97.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (10 grants) versus a trough of 2 in 2015. By volume, Medtentia sits between Malwarebytes Inc. and Minimax GmbH & Co KG.
Medtentia's three-year grant acceleration
From 2019–2021 to 2022–2024, Medtentia International Ltd Oy moved from 20 to 11 grants (0.55x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at Medtentia's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Malwarebytes
Malwarebytes Inc.
38 patents
- Marvin Lumber and…
Marvin Lumber and Cedar Company, LLC
38 patents
- Mccain Foods
McCain Foods Limited
38 patents
- Mckesson Financia…
McKesson Financial Holdings Unlimited Company
38 patents
- Merative US
Merative US L.P.
38 patents
- Micronas
Micronas GmbH
38 patents
- Mikron Industries
Mikron Industries, Inc.
38 patents
- Minimax & KG
Minimax GmbH & Co KG
38 patents
- Medtentia Interna… ◀
Medtentia International Ltd Oy
38 patents
What this shows Medtentia holds 38 patents at rank #8,440, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Medtentia
By rank, the assignees closest to #8,440 in granted patent volume.
- Malwarebytes Inc. #8,436 · 38 patents
- Marvin Lumber and Cedar Company, LLC #8,437 · 38 patents
- McCain Foods Limited #8,438 · 38 patents
- McKesson Financial Holdings Unlimited Company #8,439 · 38 patents
- Merative US L.P. #8,441 · 38 patents
- Micronas GmbH #8,442 · 38 patents
- Mikron Industries, Inc. #8,443 · 38 patents
- Minimax GmbH & Co KG #8,444 · 38 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in Medtentia's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Medtentia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Medtentia ranks #174 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (32 here).
Medtentia's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
32 39th percentile higher than 39% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 5.3% |
| 2016 | 2 | 5.3% |
| 2018 | 3 | 7.9% |
| 2019 | 10 | 26.3% |
| 2020 | 5 | 13.2% |
| 2021 | 5 | 13.2% |
| 2022 | 7 | 18.4% |
| 2023 | 4 | 10.5% |
Which technologies does Medtentia International Ltd Oy patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Medtentia International Ltd Oy's patent record in context - here's where to go next.
- Medtentia International Ltd Oy's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 97.4% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #8,435 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Medtentia International Ltd Oy against Malwarebytes Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.